Group effects EMA [Two-Stage / GS Designs]

posted by VStus – Poland, 2016-10-07 00:06 (2752 d 16:02 ago) – Posting: # 16701
Views: 35,504

Hi Helmut,

I have performed exercise on this dataset in R and have to support Mittyri: addition of more effects beyond group increases MSE and, therefore, CI:

anova(lm(log(response) ~ sequence + subject:sequence + period + treatment, data=data, na.action=na.exclude))["Residuals","Mean Sq"]
[1] 0.00075363
anova(lm(log(response) ~ sequence + subject:sequence + period + treatment + group, data=data, na.action=na.exclude))["Residuals","Mean Sq"]
[1] 0.00075363
anova(lm(log(response) ~ sequence + subject:sequence + period + treatment + group + period:group, data=data, na.action=na.exclude))["Residuals","Mean Sq"]
[1] 0.00078534


Due to my limited R knowledge, I cannot figure out how to add other effects recommended by FDA e.g. subject(sequence x group), but I'm afraid that at least in R, the more related effects - the wider confidence intervals...

Regards, VStus

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,654 registered users;
109 visitors (0 registered, 109 guests [including 3 identified bots]).
Forum time: 16:09 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5